Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336278
Status:
COMPLETED
Last Update Posted:
2024-04-22
First Post:
2024-03-19
Brief Title:
Relationship Between Central Sensitization and Kinesiophobia in Knee Osteoarthritis
Sponsor:
Selda Sarıkaya
Organization:
Bulent Ecevit University
Study Overview
Official Title:
The Relationship Between Central Sensitization and Kinesiophobia in Patients With Knee Osteoarthritis
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective The knee joint is one of most common locations in OA In recent years it has been accepted that there are different pain phenotypes and patient subgroups in knee OA and that central sensitization CS mechanisms are at the forefront in some patients It is also known that fear of movement known as kinesiophobia develops in patients with chronic pain The aim of this study is to investigate CS and kinesiophobia in patients with knee OA their relationships with each other and their effects on pain intensity functional status pain catastrophizing and depression
Materials and Methods Forty-two patients with knee OA and 42 healthy subjects participated in our study Demographic data body mass index habits comorbidities medications of participants and disease duration and radiographic grade of knee OA patients were recorded VAS was used to assess the severity of pain and WOMAC was used to assess pain and functional status in patients with OA Algometer pressure pain threshold measurement and Central Sensitization Inventory were used to evaluate central sensitization in all participants Pressure pain threshold PPT was measured at 3 different points knee joint cruris and forearm The presence of kinesiophobia was assessed with the Tampa Scale af Kinesiophobia TSK Pain Catastrophizing Scale PCS and Beck Depression Inventory BDI were used to assess chronic pain related symptoms
Materials and Methods Forty-two patients with knee OA and 42 healthy subjects participated in our study Demographic data body mass index habits comorbidities medications of participants and disease duration and radiographic grade of knee OA patients were recorded VAS was used to assess the severity of pain and WOMAC was used to assess pain and functional status in patients with OA Algometer pressure pain threshold measurement and Central Sensitization Inventory were used to evaluate central sensitization in all participants Pressure pain threshold PPT was measured at 3 different points knee joint cruris and forearm The presence of kinesiophobia was assessed with the Tampa Scale af Kinesiophobia TSK Pain Catastrophizing Scale PCS and Beck Depression Inventory BDI were used to assess chronic pain related symptoms
Detailed Description:
Forty-two patients with knee OA and 42 healthy subjects participated in our study Demographic data body mass index habits comorbidities medications of participants and disease duration and radiographic grade of knee OA patients were recorded VAS was used to assess the severity of pain and WOMAC was used to assess pain and functional status in patients with OA Algometer pressure pain threshold measurement and Central Sensitization Inventory were used to evaluate central sensitization in all participants Pressure pain threshold PPT was measured at 3 different points knee joint cruris and forearm The presence of kinesiophobia was assessed with the Tampa Scale af Kinesiophobia TSK Pain Catastrophizing Scale PCS and Beck Depression Inventory BDI were used to assess chronic pain related symptoms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None